These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23901271)

  • 41. Optimized Nanoparticles for Enhanced Oral Bioavailability of a Poorly Soluble Drug: Solid Lipid Nanoparticles Versus Nanostructured Lipid Carriers.
    Darwish MKM; El-Enin ASMA; Mohammed KHA
    Pharm Nanotechnol; 2022; 10(1):69-87. PubMed ID: 35142275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.
    Zhang T; Chen J; Zhang Y; Shen Q; Pan W
    Eur J Pharm Sci; 2011 Jun; 43(3):174-9. PubMed ID: 21530654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles - Formulation and Pharmacodynamic Assessment.
    Awadeen RH; Boughdady MF; Meshali MM
    Int J Nanomedicine; 2020; 15():8553-8568. PubMed ID: 33173292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
    Abdelbary G; Haider M
    Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects.
    Shi F; Wei Z; Zhao Y; Xu X
    Pharmacogn Mag; 2016; 12(47):198-202. PubMed ID: 27601850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy.
    Alam T; Pandit J; Vohora D; Aqil M; Ali A; Sultana Y
    Expert Opin Drug Deliv; 2015 Feb; 12(2):181-94. PubMed ID: 25164097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
    Pradhan M; Singh D; Murthy SN; Singh MR
    Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization,
    Abdelmonem R; Al-Samadi IEI; El Nashar RM; Jasti BR; El-Nabarawi MA
    Drug Deliv; 2022 Dec; 29(1):2868-2882. PubMed ID: 36065090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 51. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers.
    Xu X; Zhao C; Yang H; Jian Y; Zhang Z; Huang Y
    Drug Deliv; 2011; 18(7):485-92. PubMed ID: 21692681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.
    Elnaggar YS; El-Massik MA; Abdallah OY
    Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
    Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
    Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.
    Ali Z; Din FU; Zahid F; Sohail S; Imran B; Khan S; Malik M; Zeb A; Khan GM
    BMC Pharmacol Toxicol; 2022 Nov; 23(1):86. PubMed ID: 36443818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carvacrol loaded nanostructured lipid carriers as a promising parenteral formulation for leishmaniasis treatment.
    Galvão JG; Santos RL; Silva ARST; Santos JS; Costa AMB; Chandasana H; Andrade-Neto VV; Torres-Santos EC; Lira AAM; Dolabella S; Scher R; Kima PE; Derendorf H; Nunes RS
    Eur J Pharm Sci; 2020 Jul; 150():105335. PubMed ID: 32272211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Box-Behnken study design for optimization of bicalutamide-loaded nanostructured lipid carrier: stability assessment.
    Kudarha R; Dhas NL; Pandey A; Belgamwar VS; Ige PP
    Pharm Dev Technol; 2015; 20(5):608-18. PubMed ID: 24785784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast.
    Madan JR; Khobaragade S; Dua K; Awasthi R
    Dermatol Ther; 2020 May; 33(3):e13370. PubMed ID: 32250507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.
    Emami J; Rezazadeh M; Sadeghi H; Khadivar K
    Pharm Dev Technol; 2017 May; 22(3):370-382. PubMed ID: 27689412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.